Showing results (491-500 of 536) with videos related to
Sort By:
Pageof 54
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2011
Restoration of T cell responses to toxoplasma gondii after successful combined antiretroviral therapy in patients with AIDS with previous toxoplasmic encephalitisMarylène Lejeune, José M Miró, Elisa De Lazzari, et al.Journal of Personalized Medicine|June 14, 2014
Design and implementation of a randomized controlled trial of genomic counseling for patients with chronic diseaseKevin Sweet, Erynn S Gordon, Amy C Sturm, et al.Antiviral Therapy|February 6, 2004
Predictors of tonsillar tissue HIV-1 viral burden at baseline and after 1 year of antiretroviral therapyPilar Navarrete, Vanessa Morente, Felipe García, et al.International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 9, 2026
Real-World Experience with Cefiderocol in Hematologic Patients with MalignanciesAna Martinez-Urrea, Laura Mezzogori, Antonio Gallardo-Pizarro, et al.Vaccines|December 11, 2019
Therapeutic Vaccine in Chronically HIV-1-Infected Patients: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Trial with HTI-TriMixWesley de Jong, Lorna Leal, Jozefien Buyze, et al.Plos One|February 2, 2011
A new multidisciplinary home care telemedicine system to monitor stable chronic human immunodeficiency virus-infected patients: a randomized studyAgathe León, César Cáceres, Emma Fernández, et al.Journal of Virology|August 26, 2011
The HIV/AIDS vaccine candidate MVA-B administered as a single immunogen in humans triggers robust, polyfunctional, and selective effector memory T cell responses to HIV-1 antigensCarmen Elena Gómez, José Luis Nájera, Beatriz Perdiguero, et al.Nutrients|April 3, 2021
Adherence to a Supplemented Mediterranean Diet Drives Changes in the Gut Microbiota of HIV-1-Infected IndividualsRoque Pastor-Ibáñez, Juan Blanco-Heredia, Florencia Etcheverry, et al.Vaccines|January 22, 2024
Assessment of Human SARS CoV-2-Specific T-Cell Responses Elicited In Vitro by New Computationally Designed mRNA Immunogens (COVARNA)Ignasi Esteban, Carmen Pastor-Quiñones, Lorena Usero, et al.The Journal of Clinical Investigation|November 29, 2024
Assessing advances in three decades of clinical antiretroviral therapy on the HIV-1 reservoirIrene González-Navarro, Víctor Urrea, Cristina Gálvez, et al.Pageof 54